<html>
<head>PUBMED IDs for ABIN-3</head>
<body bgcolor='#C5F0F2'><h1>ABIN-3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17088249/'>LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-kappaB activation.</a> November 8  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17485448/'>ABIN-3: a molecular basis for species divergence in interleukin-10-induced anti-inflammatory actions.</a> May 9  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18081698/'>Expression of the NF-kappaB inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappaB.</a> December 18  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19378032/'>Cellular expression of A20 and ABIN-3 in response to Toll-like receptor-4 stimulation.</a> May 23  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19464428/'>ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.</a> June 18  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20362473/'>Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins.</a> May 7  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22525270/'>A20/TNFAIP3 inhibits NF-ÎºB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.</a> August 2  2012<br></body></html>
